One idea I haven’t seen mentioned yet is the importance of building internal minimal oversight expertise even if the company outsources everything else. A smaller company might not have a full clinica...

I would lean toward choosing a Y-type employee, but not just because they’re more motivated, more because they tend to be more adaptable over time. In most roles, especially in changing environments, ...

One thing I haven’t seen mentioned yet is that this issue could have been avoided earlier if the team had set clear acceptance criteria for the pouches before ordering. Since odor wasn’t treated as a ...

One aspect that hasn’t been discussed much is the use of scenario-based planning and simulation models in clinical trial design. Instead of relying on a single projected timeline or budget, teams coul...

One aspect that hasn’t been discussed much is the role of post-market surveillance and real-world data analytics in preventing and managing recalls. Instead of reacting only after adverse events are r...

One additional approach could be using decentralized or hybrid clinical trials, where some parts of the study (like follow-ups or monitoring) are done remotely. This can make participation easier for ...

I think your point about budgets acting as a negotiation tool early on is really interesting, and it raises an important question about whether budgets reflect reality or strategy. In many cases, espe...

I really like the focus on prioritization and balancing compliance vs. discretionary changes. One additional angle that could help with unknown budgets is incremental funding or stage-gate budgeting. ...

I really like the points raised about assumptions and knowledge transfer. One additional challenge I think isn’t talked about as much is decision latency and feedback loops. In many projects, especial...

One thing I think is really helpful is breaking requirements into must-have vs nice-to-have. In biomedical projects, especially during something like COVID, new ideas and features come up constantly, ...

One aspect that hasn’t been discussed much is how project management tools support regulatory decision-making and traceability, which is important in medical device development. Beyond scheduling and ...

One approach that hasn’t been discussed yet is using a visual impact assessment, such as a simple impact matrix or dashboard, to quickly show how a proposed change affects important project areas like...

I agree that the board of directors mainly operates at a high level and is not involved in day-to-day project execution, but one aspect that stood out to me is their role in risk tolerance and decisio...

I like the points about traceability and feedback loops, but one thing I think is also important is the use of real-time monitoring dashboards and leading indicators, not just lagging ones like comple...

I agree with the idea of building buffer time and finding alternative paths, but one thing I think is really important that hasn’t been emphasized as much is task decoupling and parallelization. When ...